These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14313494)

  • 1. EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PROTECTION EXPERIMENTS WITH ENCEPHALITOGENIC FACTOR AND TUBERCLE FRACTIONS.
    CUNNINGHAM VR; FIELD EJ
    Ann N Y Acad Sci; 1965 Mar; 122():346-55. PubMed ID: 14313494
    [No Abstract]   [Full Text] [Related]  

  • 2. SUBSTITUTES FOR THE MYCOBACTERIA IN FREUND'S ADJUVANTS IN THE PRODUCTION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN THE GUINEA PIG.
    SHAW CM; ALVORD EC; FAHLBERG WJ; KIES MW
    J Immunol; 1964 Jan; 92():28-40. PubMed ID: 14139543
    [No Abstract]   [Full Text] [Related]  

  • 3. STRAIGHT CHAIN HYDROCARBONS AS SUBSTITUTES FOR THE OIL IN FREUND'S ADJUVANTS IN THE PRODUCTION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN THE GUINEA PIG.
    SHAW CM; ALVORD EC; KIES MW
    J Immunol; 1964 Jan; 92():24-7. PubMed ID: 14139542
    [No Abstract]   [Full Text] [Related]  

  • 4. AN ANALYSIS OF COMPONENTS OF FREUND'S ADJUVANTS IN THE PRODUCTION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN THE GUINEA PIG.
    ALVORD EC; SHAW CM; FAHLBERG WJ; KIES MW
    Z Immunitats Allergieforsch; 1964 Mar; 126():193-208. PubMed ID: 14185397
    [No Abstract]   [Full Text] [Related]  

  • 5. CHRONIC DISSEMINATED ALLERGIC ENCEPHALOMYELITIS IN GUINEA PIGS.
    STONE SH; LERNER EM
    Ann N Y Acad Sci; 1965 Mar; 122():227-41. PubMed ID: 14313480
    [No Abstract]   [Full Text] [Related]  

  • 6. PROTECTIVE EFFECT OF ENCEPHALITOGENIC FACTOR IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS.
    FIELD EJ; CASPARY EA
    Nature; 1964 Feb; 201():936. PubMed ID: 14132801
    [No Abstract]   [Full Text] [Related]  

  • 7. EFFECT OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS ON GUINEA PIG PLASMA LIPID FRACTIONS.
    MUELLER P; KIES MW; ALVORD EC; YAMAMOTO RS
    Proc Soc Exp Biol Med; 1964 Apr; 115():1095-9. PubMed ID: 14166568
    [No Abstract]   [Full Text] [Related]  

  • 8. ADJUVANTS AND ASPERMATOGENESIS IN THE GUINEA PIG.
    KATSH S
    Int Arch Allergy Appl Immunol; 1964; 24():319-31. PubMed ID: 14192033
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adjuvant role of the lipopolysaccharide from Bordetella pertussis in the induction of experimental allergic encephalomyelitis. Induction of a subacute form in the rabbit and inhibition of this adjuvant effect].
    Moulias R; Peetoom F
    Pathol Biol; 1968 Oct; 16(19):853-8. PubMed ID: 4302102
    [No Abstract]   [Full Text] [Related]  

  • 10. IMMUNO-CONGLUTININ LEVEL IN GUINEA PIGS WITH EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS.
    BALL EJ; CASPARY EA
    Life Sci (1962); 1963 Oct; 10():737-8. PubMed ID: 14076594
    [No Abstract]   [Full Text] [Related]  

  • 11. Complete Freund's adjuvant-induced immune prevention against experimental allergic encephalomyelitis in guinea pigs: early appearance of anti-myelin basic protein antibody.
    Akiyama K; Murakami T; Nomaguchi TA; Nagai Y
    Jpn J Exp Med; 1981 Apr; 51(2):137-9. PubMed ID: 6168789
    [No Abstract]   [Full Text] [Related]  

  • 12. FURTHER STUDIES OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN THE FOWL. II. THE INFLUENCE OF DOSE VARIATIONS ON THE HISTOLOGICAL LESIONS.
    WIGHT PA; SILLER WG
    Immunology; 1963 Nov; 6(6):513-9. PubMed ID: 14088889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AN ANALYSIS OF VARIOUS TYPES OF INHIBITION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN THE GUINEA PIG.
    ALVORD EC; SHAW CM; FAHLBERG WJ; KIES MW
    Z Immunitats Allergieforsch; 1964 Mar; 126():217-27. PubMed ID: 14185399
    [No Abstract]   [Full Text] [Related]  

  • 14. COMPLEMENT LEVELS IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS.
    TARRANT CJ; FIFE EH; MUSCHEL LH
    Nature; 1964 May; 202():819. PubMed ID: 14187643
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON THE PATHOGENESIS OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS].
    TSAREGORODTSEVA TM
    Vestn Akad Med Nauk SSSR; 1964; 19():78-84. PubMed ID: 14198180
    [No Abstract]   [Full Text] [Related]  

  • 16. PSEUDOMONAS PSEUDOMALEI AND PSEUDOMONAS AERUGINOSA AS ADJUVANTS IN THE PRODUCTION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS.
    LIPTON MM; STEIGMAN AJ
    J Immunol; 1963 Apr; 90():512-7. PubMed ID: 14082012
    [No Abstract]   [Full Text] [Related]  

  • 17. ENCEPHALITOGEN-INDUCED INHIBITION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PREVENTION, SUPPRESSION AND THERAPY.
    ALVORD EC; SHAW CM; HRUBY S; KIES MW
    Ann N Y Acad Sci; 1965 Mar; 122():333-45. PubMed ID: 14313493
    [No Abstract]   [Full Text] [Related]  

  • 18. [ASPARAGINASE ACTIVITY IN THE NERVOUS SYSTEM IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS. II].
    TURSKY T; VALOVICOVA E
    Cas Lek Cesk; 1964 Apr; 103():395-400. PubMed ID: 14160298
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative relationship for adjuvanticity between antigen and adjuvant.
    Tanaka A; Anaka K; Hagimoto D; Sugiyama K
    Int Arch Allergy Appl Immunol; 1967; 32(2):224-35. PubMed ID: 4965711
    [No Abstract]   [Full Text] [Related]  

  • 20. [EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS, MORPHOLOGY OF THE CENTRAL NERVOUS AND THYMICO-LYMPHATIC SYSTEMS].
    RAVKINA LI
    Vestn Akad Med Nauk SSSR; 1963; 18():57-60. PubMed ID: 14150476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.